Kilitch Drugs (India) Limited (KILITCH) - Total Assets

Latest as of September 2025: Rs3.99 Billion INR ≈ $43.11 Million USD

Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) holds total assets worth Rs3.99 Billion INR (≈ $43.11 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See KILITCH book value for net asset value and shareholders' equity analysis.

Kilitch Drugs (India) Limited - Total Assets Trend (2006–2025)

This chart illustrates how Kilitch Drugs (India) Limited's total assets have evolved over time, based on quarterly financial data.

Kilitch Drugs (India) Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Kilitch Drugs (India) Limited's total assets of Rs3.99 Billion consist of 55.6% current assets and 44.4% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs28.69 Million	3.1%
Accounts Receivable	Rs847.39 Million	27.1%
Inventory	Rs153.10 Million	4.9%
Property, Plant & Equipment	Rs928.19 Million	29.7%
Intangible Assets	Rs188.87 Million	6.0%
Goodwill	Rs185.36 Million	5.9%

Asset Composition Trend (2006–2025)

This chart illustrates how Kilitch Drugs (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Kilitch Drugs (India) Limited.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Kilitch Drugs (India) Limited's current assets represent 55.6% of total assets in 2025, an increase from 33.3% in 2006.
Cash Position: Cash and equivalents constituted 3.1% of total assets in 2025, up from 0.5% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is property, plant & equipment at 29.7% of total assets.

Kilitch Drugs (India) Limited Competitors by Total Assets

Key competitors of Kilitch Drugs (India) Limited based on total assets are shown below.

Company	Country	Total Assets
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion

Kilitch Drugs (India) Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.53	2.09	1.01
Quick Ratio	2.37	2.01	0.97
Cash Ratio	0.40	0.08	0.00
Working Capital	Rs1.26 Billion	Rs768.97 Million	Rs3.47 Million

Kilitch Drugs (India) Limited - Advanced Valuation Insights

This section examines the relationship between Kilitch Drugs (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.82
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	30.3%
Total Assets	Rs3.13 Billion
Market Capitalization	$58.23 Million USD

Valuation Analysis

Below Book Valuation: The market values Kilitch Drugs (India) Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Kilitch Drugs (India) Limited's assets grew by 30.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Kilitch Drugs (India) Limited (2006–2025)

The table below shows the annual total assets of Kilitch Drugs (India) Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs3.13 Billion ≈ $33.83 Million	+30.29%
2024-03-31	Rs2.40 Billion ≈ $25.96 Million	+9.36%
2023-03-31	Rs2.20 Billion ≈ $23.74 Million	+4.61%
2022-03-31	Rs2.10 Billion ≈ $22.69 Million	+3.28%
2021-03-31	Rs2.03 Billion ≈ $21.97 Million	+42.25%
2020-03-31	Rs1.43 Billion ≈ $15.45 Million	-0.58%
2019-03-31	Rs1.44 Billion ≈ $15.54 Million	+12.52%
2018-03-31	Rs1.28 Billion ≈ $13.81 Million	+13.09%
2017-03-31	Rs1.13 Billion ≈ $12.21 Million	-3.25%
2016-03-31	Rs1.17 Billion ≈ $12.62 Million	-7.93%
2015-03-31	Rs1.27 Billion ≈ $13.71 Million	-1.81%
2014-03-31	Rs1.29 Billion ≈ $13.96 Million	-5.70%
2013-03-31	Rs1.37 Billion ≈ $14.80 Million	-22.64%
2012-03-31	Rs1.77 Billion ≈ $19.13 Million	+9.73%
2011-03-31	Rs1.61 Billion ≈ $17.44 Million	+16.62%
2010-03-31	Rs1.38 Billion ≈ $14.95 Million	-3.16%
2009-03-31	Rs1.43 Billion ≈ $15.44 Million	+8.58%
2008-03-31	Rs1.31 Billion ≈ $14.22 Million	+86.94%
2007-03-31	Rs703.40 Million ≈ $7.61 Million	+58.88%
2006-03-31	Rs442.74 Million ≈ $4.79 Million	--

About Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic

Market Cap

$58.23 Million

Rs5.38 Billion INR

Market Cap Rank

#21298 Global

#1163 in India

Share Price

Rs154.02

Change (1 day)

-0.06%

52-Week Range

Rs124.45 - Rs487.85

All Time High

Rs487.85